Sun Pharmaceutical Industries Limited has informed the Exchange about Link of Recording
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharma has informed the stock exchanges that the audio recording of its Q4 FY25 earnings call, held on May 22, 2025, is now available on the company's website. This is a routine regulatory disclosure submitted under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30). The filing follows the company's earlier intimation dated May 12, 2025 about the earnings call. The link to the MP3 recording has been shared with both NSE and BSE. No new financial details or management commentary are included in this filing itself.
This is a procedural disclosure with no immediate direct impact on the stock price. However, investors should listen to the earnings call recording for any management guidance on margins, revenue outlook, or strategy that could shape future sentiment.